476
|
Chen YC, Tsai MF. Using surfactants to enhance the analyte signals in activated carbon, surface-assisted laser desorption/ionization (SALDI) mass spectrometry. JOURNAL OF MASS SPECTROMETRY : JMS 2000; 35:1278-1284. [PMID: 11114085 DOI: 10.1002/1096-9888(200011)35:11<1278::aid-jms59>3.0.co;2-z] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
The effect of surface activity in surface-assisted laser desorption/ionization (SALDI) mass spectrometry was examined. Several surfactants, including p-tolunensulfonic acid (PTSA), sodium dodecyl sulfate and alkyltrimethylammonium bromide, were used as analytes or additives in the SALDI matrix to demonstrate the surface activity effect. The experimental results demonstrate that analytes that have good surface activity have good sensitivity. Adding suitable amounts of surfactants to the SALDI matrix can dramatically enhance the sensitivity of analytes lacking surface activity. We propose that the enhancement of analyte signals is due to the ionic interaction between ionic surfactants and analytes because non-ionic surfactant additives in the SALDI matrix do not affect the analyte signals. The detection limit of methylephedrine can be as low as 100 pg in the SALDI analysis of 0.5 M PTSA additive in the SALDI matrix. Although other surfactants can also be used as matrix additives to enhance the analyte signal, they do not improve the ion abundance as much as PTSA does.
Collapse
|
477
|
Chi CJ, Chen YC, Chen HH, Yeh JC. Pathological differences in nephrotic-range proteinuria with and without hypoalbuminemia. Nephron Clin Pract 2000; 86:372-3. [PMID: 11096309 DOI: 10.1159/000045807] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
|
478
|
Chen CY, Chen YC, Fang JT, Huang CC. Continuous arteriovenous hemodiafiltration in the acute treatment of hyperammonaemia due to ornithine transcarbamylase deficiency. Ren Fail 2000; 22:823-36. [PMID: 11104170 DOI: 10.1081/jdi-100101968] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
BACKGROUND Acute hyperammonemia caused by urea cycle disorder is a medical emergency for which immediate managements should be taken to minimize permanent brain damage. Among different enzyme defects, ornithine transcarbamylase deficiency (OTC) is one of the most common enzyme defect in urea cycle disorders. We utilized continuous renal replacement therapy techniques in the acute treatment of hyperammonemia due to ornithine transcarbamylase deficiency. PATIENTS AND METHODS Three male neonates with elevated serum ammonia levels were shown, based on urine organic acid analysis and serum amino acid studies, to have OTC deficiency. Administration of sodium benzoate and sodium phenylacetate for activating alternative nitrogen waste pathway were used associated with protein restriction. Other modalities, including blood exchange transfusion, peritoneal dialysis, continuous renal replacement therapy were utilized in an attempt to lower serum ammonia concentration. RESULTS We report the successful use of continuous arteriovenous hemofiltration (CAVH), continuous arteriovenous hemodialysis (CAVHD), continuous arteriovenous hemodiafiltration (CAVHDF) in the acute management of hyperammonemia due to OTC deficiency. We also compared the ammonia clearance between peritoneal dialysis, exchange transfusion, CAVH, CAVHD and CAVHDF. It demonstrated the evidence that CAVHDF provides the best ammonia clearance. CONCLUSION Continuous renal replacement therapy including CAVH, CAVHD, and CAVHDF may be the alternative techniques for acute management of hyperammonemia in inborn error of metabolism when dialysis machine is not available. Our data suggests CAVHDF provides the best ammonia clearance.
Collapse
|
479
|
Affolder T, Akimoto H, Akopian A, Albrow MG, Amaral P, Amendolia SR, Amidei D, Anikeev K, Antos J, Apollinari G, Arisawa T, Asakawa T, Ashmanskas W, Atac M, Azfar F, Azzi-Bacchetta P, Bacchetta N, Bailey MW, Bailey S, de Barbaro P, Barbaro-Galtieri A, Barnes VE, Barnett BA, Barone M, Bauer G, Bedeschi F, Belforte S, Bellettini G, Bellinger J, Benjamin D, Bensinger J, Beretvas A, Berge JP, Berryhill J, Bevensee B, Bhatti A, Binkley M, Bisello D, Blair RE, Blocker C, Bloom K, Blumenfeld B, Blusk SR, Bocci A, Bodek A, Bokhari W, Bolla G, Bonushkin Y, Bortoletto D, Boudreau J, Brandl A, van den Brink S, Bromberg C, Brozovic M, Bruner N, Buckley-Geer E, Budagov J, Budd HS, Burkett K, Busetto G, Byon-Wagner A, Byrum KL, Calafiura P, Campbell M, Carithers W, Carlson J, Carlsmith D, Cassada J, Castro A, Cauz D, Cerri A, Chan AW, Chang PS, Chang PT, Chapman J, Chen C, Chen YC, Cheng MT, Chertok M, Chiarelli G, Chirikov-Zorin I, Chlachidze G, Chlebana F, Christofek L, Chu ML, Ciobanu CI, Clark AG, Connolly A, Conway J, Cooper J, Cordelli M, Cranshaw J, Cronin-Hennessy D, Cropp R, Culbertson R, Dagenhart D, DeJongh F, Dell'Agnello S, Dell'Orso M, Demina R, Demortier L, Deninno M, Derwent PF, Devlin T, Dittmann JR, Donati S, Done J, Dorigo T, Eddy N, Einsweiler K, Elias JE, Engels E, Erdmann W, Errede D, Errede S, Fan Q, Feild RG, Ferretti C, Field RD, Fiori I, Flaugher B, Foster GW, Franklin M, Freeman J, Friedman J, Fukui Y, Furic I, Galeotti S, Gallinaro M, Gao T, Garcia-Sciveres M, Garfinkel AF, Gatti P, Gay C, Geer S, Gerdes DW, Giannetti P, Giromini P, Glagolev V, Gold M, Goldstein J, Gordon A, Goshaw AT, Gotra Y, Goulianos K, Green C, Groer L, Grosso-Pilcher C, Guenther M, Guillian G, Guimaraes da Costa J, Guo RS, Haas RM, Haber C, Hafen E, Hahn SR, Hall C, Handa T, Handler R, Hao W, Happacher F, Hara K, Hardman AD, Harris RM, Hartmann F, Hatakeyama K, Hauser J, Heinrich J, Heiss A, Herndon M, Hinrichsen B, Hoffman KD, Holck C, Hollebeek R, Holloway L, Hughes R, Huston J, Huth J, Ikeda H, Incandela J, Introzzi G, Iwai J, Iwata Y, James E, Jensen H, Jones M, Joshi U, Kambara H, Kamon T, Kaneko T, Karr K, Kasha H, Kato Y, Keaffaber TA, Kelley K, Kelly M, Kennedy RD, Kephart R, Khazins D, Kikuchi T, Kilminster B, Kirby M, Kirk M, Kim BJ, Kim DH, Kim HS, Kim MJ, Kim SH, Kim YK, Kirsch L, Klimenko S, Koehn P, Köngeter A, Kondo K, Konigsberg J, Kordas K, Korn A, Korytov A, Kovacs E, Kroll J, Kruse M, Kuhlmann SE, Kurino K, Kuwabara T, Laasanen AT, Lai N, Lami S, Lammel S, Lamoureux JI, Lancaster M, Latino G, LeCompte T, Lee AM, Lee K, Leone S, Lewis JD, Lindgren M, Liss TM, Liu JB, Liu YC, Lockyer N, Loken J, Loreti M, Lucchesi D, Lukens P, Lusin S, Lyons L, LysV J, Madrak R, Maeshima K, Maksimovic P, Malferrari L, Mangano M, Mariotti M, Martignon G, Martin A, Matthews JA, Mayer J, Mazzanti P, McFarland KS, McIntyre P, McKigney E, Menguzzato M, Menzione A, Mesropian C, Miao T, Miller R, Miller JS, Minato H, Miscetti S, Mishina M, Mitselmakher G, Moggi N, Moore E, Moore R, Morita Y, Mulhearn M, Mukherjee A, Muller T, Munar A, Murat P, Murgia S, Musy M, Nachtman J, Nahn S, Nakada H, Nakaya T, Nakano I, Nelson C, Neuberger D, Newman-Holmes C, Ngan CY, Nicolaidi P, Niu H, Nodulman L, Nomerotski A, Oh SH, Ohmoto T, Ohsugi T, Oishi R, Okusawa T, Olsen J, Orejudos W, Pagliarone C, Palmonari F, Paoletti R, Papadimitriou V, Pappas SP, Partos D, Patrick J, Pauletta G, Paulini M, Paus C, Pescara L, Phillips TJ, Piacentino G, Pitts KT, Plunkett R, Pompos A, Pondrom L, Pope G, Popovic M, Prokoshin F, Proudfoot J, Ptohos F, Pukhov O, Punzi G, Ragan K, Rakitine A, Reher D, Reichold A, Riegler W, Ribon A, Rimondi F, Ristori L, Robertson WJ, Robinson A, Rodrigo T, Rolli S, Rosenson L, Roser R, Rossin R, Safonov A, Sakumoto WK, Saltzberg D, Sansoni A, Santi L, Sato H, Savard P, Schlabach P, Schmidt EE, Schmidt MP, Schmitt M, Scodellaro L, Scott A, Scribano A, Segler S, Seidel S, Seiya Y, Semenov A, Semeria F, Shah T, Shapiro MD, Shepard PF, Shibayama T, Shimojima M, Shochet M, Siegrist J, Signorelli G, Sill A, Sinervo P, Singh P, Slaughter AJ, Sliwa K, Smith C, Snider FD, Solodsky A, Spalding J, Speer T, Sphicas P, Spinella F, Spiropulu M, Spiegel L, Steele J, Stefanini A, Strologas J, Strumia F, Stuart D, Sumorok K, Suzuki T, Takano T, Takashima R, Takikawa K, Tamburello P, Tanaka M, Tannenbaum B, Taylor W, Tecchio M, Teng PK, Terashi K, Tether S, Theriot D, Thurman-Keup R, Tipton P, Tkaczyk S, Tollefson K, Tollestrup A, Toyoda H, Trischuk W, de Troconiz JF, Tseng J, Turini N, Ukegawa F, Vaiciulis T, Valls J, Vejcik S, Velev G, Vidal R, Vilar R, Volobouev I, Vucinic D, Wagner RG, Wagner RL, Wahl J, Wallace NB, Walsh AM, Wang C, Wang CH, Wang MJ, Watanabe T, Waters D, Watts T, Webb R, Wenzel H, Wester WC, Wicklund AB, Wicklund E, Williams HH, Wilson P, Winer BL, Winn D, Wolbers S, Wolinski D, Wolinski J, Wolinski S, Worm S, Wu X, Wyss J, Yagil A, Yao W, Yeh GP, Yeh P, Yoh J, Yosef C, Yoshida T, Yu I, Yu S, Yu Z, Zanetti A, Zetti F, Zucchelli S. Measurement of J/psi and psi(2S) polarization in pp collisions at sqrt[s] = 1.8 TeV. PHYSICAL REVIEW LETTERS 2000; 85:2886-2891. [PMID: 11005960 DOI: 10.1103/physrevlett.85.2886] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/25/2000] [Indexed: 05/23/2023]
Abstract
We have measured the polarization of J/psi and psi(2S) mesons produced in pp collisions at sqrt[s] = 1.8 TeV, using data collected at the Collider Detector at Fermilab during 1992-1995. The polarization of promptly produced J/psi [psi(2S)] mesons is isolated from those produced in B-hadron decay, and measured over the kinematic range 4 [5.5]<P(T)<20 GeV/c and |y|<0.6. For P(T) greater than or approximately equal 12 GeV/c we do not observe significant polarization in the prompt component.
Collapse
|
480
|
Chang CT, Fang JT, Chen YC, Chang MY. Peripheral venopuncture as temporary vascular access in rhabdomyolysis-induced acute renal failure related to frog leaps: case report. CHANG GUNG MEDICAL JOURNAL 2000; 23:619-23. [PMID: 11126154] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
Abstract
Rhabdomyolysis, or acute muscle destruction, may be accompanied by myoglobinemia, myoglobinuria, and an elevated serum creatine kinase level. The disorder has many potential causes, the most common one in otherwise healthy people being severe exercise. Rhabdomyolysis has many complications, but the most important one is acute renal failure. We describe a man with rhabdomyolysis-induced acute renal failure occurring after frog leaps. During 3 dialytic sessions, we practiced direct puncture of peripheral veins of the antecubital fossa as temporary vascular access for this patient. His renal function improved, after which he was discharged with a smooth clinical course.
Collapse
|
481
|
Sung HW, Chang Y, Liang IL, Chang WH, Chen YC. Fixation of biological tissues with a naturally occurring crosslinking agent: fixation rate and effects of pH, temperature, and initial fixative concentration. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH 2000; 52:77-87. [PMID: 10906677 DOI: 10.1002/1097-4636(200010)52:1<77::aid-jbm10>3.0.co;2-6] [Citation(s) in RCA: 89] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
In an attempt to overcome the cytotoxicity problem of the glutaraldehyde-fixed tissues, a naturally occurring crosslinking agent (genipin) was used by our group to fix biological tissues. The study was intended to investigate the rate of tissue fixation by genipin. Glutaraldehyde was used as a control. In addition, the degrees of tissue fixation by genipin at different pHs (pH 4.0, pH 7. 4, pH 8.5, or pH 10.5), temperatures (4 degrees C, 25 degrees C, 37 degrees C, or 45 degrees C), and initial fixative concentrations (0.250%, 0.625%, or 1.000%) were examined. The results obtained revealed that the rate of tissue fixation by glutaraldehyde was significantly faster than that by genipin. The degree of tissue fixation by genipin may be controlled by adjusting its fixation duration or fixation conditions. The order in degree of tissue fixation by genipin at different pHs, from high to low, was: at nearly neutral pH (pH 7.4 or pH 8.5) > at basic pH (pH 10.5) > at acidic pH (pH 4.0). The degrees of tissue fixation by genipin at different temperatures were about the same, except for that at 4 degrees C. In contrast, the initial fixative concentration did not seem to affect the degree of tissue fixation by genipin, if only the amount of genipin in the fixation solution was sufficient to complete tissue fixation. The concentrations of genipin in the aqueous solutions at different pHs, temperatures, and initial fixative concentrations tended to decrease with time with or without the occurrence of tissue fixation. This indicated that genipin was not stable in the aqueous solution. The instability of aqueous genipin was more remarkable with increasing pH or temperature. The results obtained in this study may be used to optimize the fixation process for developing bioprostheses fixed by genipin.
Collapse
|
482
|
Lu CH, Lee KC, Chen YC, Cheng JS, Yu MS, Chen WC, Jan CR. Lindane (gamma-hexachlorocyclohexane) induces internal Ca2+ release and capacitative Ca2+ entry in Madin-Darby canine kidney cells. PHARMACOLOGY & TOXICOLOGY 2000; 87:149-55. [PMID: 11097267 DOI: 10.1034/j.1600-0773.2000.d01-65.x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
The effect of lindane (gamma-hexachlorocyclohexane), an organochlorine pesticide, on Ca2+ mobilization in Madin-Darby canine kidney cells was examined by fluorimetry using fura-2 as a Ca2+ indicator. Lindane (5-200 microM) increased [Ca2+]i concentration-dependently. The [Ca2+]i signal comprised an immediate initial rise followed by a persistent phase. Ca2+ removal inhibited the [Ca2+]i signal by reducing both the initial rise and the sustained phase. This implies lindane-triggered Ca2+ influx and Ca2+ release. In Ca2+ -free medium, 0.15 mM lindane increased [Ca2+]i after pretreatment with carbonylcyanide m-chlorophenylhydrazone (CCCP, 2 microM), a mitochondrial uncoupler, and two endoplasmic reticulum Ca2+ pump inhibitors, thapsigargin and cyclopiazonic acid. Conversely, pretreatment with lindane abolished CCCP- and thapsigargin-induced Ca2+ release. This suggests that 0.15 mM lindane released Ca2+ from the endoplasmic reticulum, mitochondria and other stores. La3+ (1 mM) partly inhibited 0.1 mM lindane-induced [Ca2+]i increase, confirming that lindane induced Ca2+ influx. Addition of 3 mM Ca2+ increased [Ca2+]i after pretreatment with 0.15 mM lindane for 750 sec. in Ca2+ -free medium, which indicates lindane-induced capacitative Ca2+ entry. Lindane (0.15 mM)-induced Ca2+ release was not reduced by inhibiting phospholipase C with 2 microM U73122, but was inhibited by 70% by the phospholipase A2 inhibitor aristolochic acid (40 microM).
Collapse
|
483
|
Tsai IL, Lin WY, Teng CM, Ishikawa T, Doong SL, Huang MW, Chen YC, Chen IS. Coumarins and antiplatelet constituents from the root bark of Zanthoxylum schinifolium. PLANTA MEDICA 2000; 66:618-623. [PMID: 11105565 DOI: 10.1055/s-2000-8648] [Citation(s) in RCA: 47] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
Further study on the chloroform-soluble portion of the root bark of Zanthoxylum schinifolium led to the isolation of eight new coumarins: methylschinilenol (1), hydroxyepoxycollinin I (2), 8-methoxyanisocoumarin H (3), hydroxyschininallylol (4), hydroxyepoxycollinin II (5), schinitrienin (6), schininallylone (7), and isoschinilenol (8), along with twenty-six known compounds including fourteen coumarins, and nine alkaloids. The structural elucidation was determined by spectroscopic data. Among the isolates, terpenyl-coumarins and furoquinolines were the active constituents with antiplatelet aggregation in vitro and collinin (10) showed significant anti-HBC DNA replication activity.
Collapse
|
484
|
Jan CR, Lu CH, Chen YC, Cheng JS, Tseng LL, Jun-Wen W. Ca(2+) mobilization induced by W-7 in MG63 human osteosarcoma cells. Pharmacol Res 2000; 42:323-7. [PMID: 10987991 DOI: 10.1006/phrs.2000.0703] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The effect of N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride (W-7), a widely used calmodulin inhibitor, on intracellular free Ca(2+)levels ([Ca(2+)](i)) in MG63 human osteosarcoma cells was explored using fura-2 as a Ca(2+)probe. W-7 (20-1000 micro m) induced an increase in [Ca(2+)](i)in a dose-dependent manner, with an EC(50)of 100 microm. The [Ca(2+)](i)signal comprised an initial rise and a sustained plateau without significant decay within 5 min. External Ca(2+)removal decreased the Ca(2+)signals by reducing the peak and sustained phase, indicating W-7-activated intracellular Ca(2+)release and extracellular Ca(2+)influx. W-7 (500 microm) failed to induce a [Ca(2+)](i)increase in a Ca(2+)-free medium after pre-treatment with thapsigargin (1 microm), an endoplasmic reticulum Ca(2+)pump inhibitor. Conversely, W-7 pre-treatment abolished the Ca(2+)release induced by thapsigargin. This suggests that W-7 (500 microm ) released internal Ca(2+)mainly from the endoplasmic reticulum. The addition of 3 mm Ca(2+)increased [Ca(2+)](i)dose-dependently after preincubation with 20-1000 microm W-7 in a Ca(2+)-free medium, implying that W-7 induced capacitative Ca(2+)entry. W-7-induced Ca(2+)release was not altered by inhibiting phospholipase C with 2 microm 1-(6-((17 beta - 3-methoxyestra-1,3, 5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione) (U73122). Tryphan blue assay demonstrated that W-7 (200 microm) caused gradual cell death within 30 min of the initial drug exposure. Together, it was found that W-7 induced [Ca(2+)](i)increases in human osteosarcoma cells by releasing internal Ca(2+)from the endoplasmic reticulum, and also by triggering Ca(2+)influx. W-7 may be cytotoxic to osteosarcoma cells.
Collapse
|
485
|
Yang CH, Schneider E, Kuo ML, Volk EL, Rocchi E, Chen YC. BCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells. Biochem Pharmacol 2000; 60:831-7. [PMID: 10930538 DOI: 10.1016/s0006-2952(00)00396-8] [Citation(s) in RCA: 89] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
We have previously described a mitoxantrone-resistant MCF7 cell line that is cross-resistant to topotecan, 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin (CPT-11), and 9-aminocamptothecin, but not to camptothecin. A novel mechanism that resulted in decreased topotecan accumulation in MCF7/MX cells was proposed (Yang et al. Cancer Res 55: 4004-4009, 1995). We now have developed a topotecan-resistant cancer cell line from wild-type MCF7 cells. MCF7/TPT300 cells were 68.9-fold resistant to topotecan, 68.3-fold to 10-hydroxy-7-ethylcamptothecin (SN-38), and 116-fold to mitoxantrone, but only 4.1-fold to camptothecin. Topotecan efflux was increased in MCF7/TPT300 cells compared with MCF7/WT cells, and this increase was reversed upon ATP depletion by sodium azide, suggesting an energy-dependent drug efflux mechanism. However, MCF7/TPT300 cells did not overexpress P-glycoprotein or the multidrug resistance-associated protein (MRP1). In contrast, overexpression of the breast cancer resistance protein (BCRP/MXR/ABCP) was observed in MCF7/TPT300 cells as well as DNA topoisomerase I down-regulation. Our data suggest that enhanced topotecan efflux contributes partly to topotecan resistance in MCF7/TPT300 cells, possibly mediated by BCRP/MXR/ABCP.
Collapse
MESH Headings
- ATP Binding Cassette Transporter, Subfamily B, Member 1/biosynthesis
- ATP Binding Cassette Transporter, Subfamily G, Member 2
- ATP-Binding Cassette Transporters/biosynthesis
- ATP-Binding Cassette Transporters/genetics
- Adenosine Triphosphate/metabolism
- Antineoplastic Agents/pharmacology
- Biological Transport
- Breast Neoplasms/enzymology
- Breast Neoplasms/metabolism
- DNA Topoisomerases, Type I/biosynthesis
- DNA Topoisomerases, Type II/biosynthesis
- DNA-Binding Proteins/biosynthesis
- Drug Resistance, Neoplasm
- Drug Screening Assays, Antitumor
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Multidrug Resistance-Associated Proteins
- MutS Homolog 3 Protein
- Neoplasm Proteins/biosynthesis
- Neoplasm Proteins/genetics
- Topotecan/pharmacology
- Tumor Cells, Cultured
Collapse
|
486
|
Chen YC, Chien RN, Chen MF, Ng KF, Tseng JH. Biliary hamartomas associated with biliary stones presenting as multiple microabscesses: case report. CHANG GUNG MEDICAL JOURNAL 2000; 23:560-5. [PMID: 11092146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
Abstract
A 63-year-old men suffered from fever, jaundice, and right upper quadrant pain for 1 week. Biliary stones with biliary tract infection were diagnosed. He was treated with parenteral antibiotics. However, abdominal ultrasonography showed multiple hyperechoic lesions in both lobes, and infiltrating hepatocellular carcinoma was suspected initially. Numerous hypervascular nodular-enhancing lesions were revealed by computed tomography. Magnetic resonance imaging further disclosed numerous tiny cystic lesions with peripheral enhancement. Exploratory laparotomy was performed for biliary calculi and probable underlying malignancy. Cholecystectomy, choledocholithotomy, and liver wedge biopsy were done. The pathology revealed bile duct hamartomas with microabscess formation. The past literature about biliary hamartomas is reviewed.
Collapse
|
487
|
Fang CT, Chen YC, Lin SF, Shau WY, Liu CJ, Sheng WH, Wang JT, Chang SC. Safety and efficacy of cefpirome in comparison with ceftazidime in Chinese patients with sepsis due to bacterial infections. Chemotherapy 2000; 46:371-8. [PMID: 10965103 DOI: 10.1159/000007311] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
BACKGROUND The safety and efficacy of cefpirome (CPM), a fourth-generation cephalosporin, has not yet been studied in an Asian population. METHODS Sixty-nine adult Chinese patients with sepsis due to bacterial infections were enrolled in the study and randomly assigned to receive CPM (2 g i.v. every 12 h) or ceftazidime (2 g i.v. every 8 h). RESULTS Both groups were comparable in terms of demographic, clinical and microbiological features. The causative pathogen was Escherichia coli or Klebsiella pneumoniae in the majority of microbiologically documented cases. The rates of clinical response (94 vs. 94%) and bacteriological response (65 vs. 68%) were similar in both groups. Similar adverse events, including rashes, gastrointestinal upset and asymptomatic elevation of hepatic enzymes, occurred in a minority of patients in both groups. All events were self-limited after discontinuation of the drugs. CONCLUSION CPM is as safe and effective as ceftazidime in the treatment of sepsis due to bacterial infections in Chinese patients.
Collapse
|
488
|
Chen YC, Bab I, Mansur N, Muhlrad A, Shteyer A, Namdar-Attar M, Gavish H, Vidson M, Chorev M. Structure-bioactivity of C-terminal pentapeptide of osteogenic growth peptide [OGP(10-14)]. THE JOURNAL OF PEPTIDE RESEARCH : OFFICIAL JOURNAL OF THE AMERICAN PEPTIDE SOCIETY 2000; 56:147-56. [PMID: 11007271 DOI: 10.1034/j.1399-3011.2000.00763.x] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
The amino acid sequence of osteogenic growth peptide (OGP) consists of 14 residues identical to the C-terminal tail of histone H4. Native and synthetic OGP are mitogenic to osteoblastic and fibroblastic cells and enhance osteogenesis and hematopoiesis in vivo. The C-terminal truncated pentapeptide of OGP, H-Tyr-Gly-Phe-Gly-Gly-OH [OGP(10-14)], is a naturally occurring osteoblastic mitogen, equipotent to OGP. The present study assesses the role of individual amino acid residues and side chains in the OGP(10-14) mitogenic activity which showed a very high correlation between osteoblastic and fibroblastic cell cultures. Truncation of either Tyr10 or its replacement by Ala or D-Ala resulted in substantial, but not complete, loss of activity. Nevertheless, only a small loss of activity was observed following removal of the Tyr10 amino group. No further loss occurred consequent to the monoiodination of desaminoTyr10 on meta-position. However, a marked decrease in proliferative activity followed removal of the Tyr10 phenolic or the Phe12 aromatic group. Loss of activity of a similar magnitude also occurred subsequent to replacing Gly11 with L- or D-Ala. Approximately 50% loss of mitogenic activity occurred subsequent to truncation of Gly14 or blocking the C-terminal group as the methyl ester. All other modifications of the C-terminus and L- or D-Ala substitution of Gly13 resulted in 70-97% decrease in activity. Collectively, these data suggest that the integrity of the pharmacophores presented by Tyr and Phe side chains, as well as the Gly residues at the C-terminus, are important for optimal bioactivity of OGP(10-14).
Collapse
|
489
|
Chen YC, Hung KY, Kao TW, Tsai TJ, Chen WY. Relationship between dialysis adequacy and quality of life in long-term peritoneal dialysis patients. Perit Dial Int 2000; 20:534-40. [PMID: 11117244] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/18/2023] Open
Abstract
OBJECTIVE The purpose of this study was to compare quality of life (QOL) between peritoneal dialysis (PD) patients with adequate and inadequate total solute clearance (TSC). We also tried to determine the relationship between QOL and TSC. DESIGN A cross-sectional study design was used in which QOL was evaluated and compared between PD patients with adequate and inadequate TSC. SETTING The PD unit of a university teaching hospital. PATIENTS Sixty-seven patients were recruited, 38 on continuous ambulatory PD and 29 on continuous cyclerassisted PD. METHODS Patients were divided into adequate and inadequate groups, based on the results of either total urea clearance (Kt/Vurea) or total creatinine clearance (weekly CCr). The demographic data, dialysis variables, and clinical parameters of these patients were all collected. QOL was evaluated using the SF-36 questionnaire, which contains eight domains and is a comprehensive and validated instrument for QOL evaluation. QOL of patients in adequate and inadequate groups was compared. The relationship between QOL and TSC was also examined. RESULTS Among patients grouped by Kt/Vurea, patients in the adequate group had significantly higher scores in two domains of the SF-36, that is, physical and emotional role functioning, than did those in the inadequate group. The total SF-36 scores were positively correlated with Kt/Vurea when all patients were pooled together. However, among patients grouped by weekly CCr, there was no significant difference in any of the eight domains of the SF-36 between patients in the adequate and inadequate groups. No correlation was found between the total SF-36 scores and weekly CCr. CONCLUSION Our study had two important findings: First, PD patients with adequate total solute clearance, based on Kt/Vurea and not on weekly CCr, had a better QOL. Second, Kt/Vurea is better correlated with QOL than weekly CCr. These findings suggest that Kt/Vurea is a better parameter for the clinical evaluation of total solute clearance from the viewpoint of QOL.
Collapse
|
490
|
Hong TM, Yang PC, Peck K, Chen JJ, Yang SC, Chen YC, Wu CW. Profiling the downstream genes of tumor suppressor PTEN in lung cancer cells by complementary DNA microarray. Am J Respir Cell Mol Biol 2000; 23:355-63. [PMID: 10970827 DOI: 10.1165/ajrcmb.23.3.4002] [Citation(s) in RCA: 60] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
The phosphatase and tensin homology deleted on chromosome 10 (PTEN) is a tumor suppressor gene with sequence homology to tyrosine phosphatases and the cytoskeletal proteins tensin and auxilin. PTEN has recently been shown to inhibit cell migration and the spreading and formation of focal adhesions. This study investigated the role of PTEN in carcinoma invasion in a lung-cancer cell line and examined the downstream genes regulated by PTEN. We have previously established a cell-line model in human lung adenocarcinoma with different invasive abilities and metastatic potentials. Examining PTEN gene expression in these cell lines, we found that a homozygous deletion in exon 5 is associated with high invasive ability. We then constructed stable constitutive and inducible wild-type PTEN-overexpressed transfectants in the highly invasive cell line CL(1-5). We found that an overexpression of PTEN can inhibit invasion in lung cancer cells. To further explore the downstream genes regulated by PTEN, a high-density complementary DNA (cDNA) microarray technique was used to profile gene changes after PTEN overexpression. Our results indicate a panel of genes that can be modulated by PTEN. PTEN overexpression downregulated genes, including integrin alpha(6), laminin beta(3), heparin-binding epidermal growth factor-like growth factor, urokinase-type plasminogen activator, myb protein B, Akt2, and some expressed sequence tag (EST) clones. In contrast, PTEN overexpression upregulated protein phosphatase 2A1B, ubiquitin protease (unph), secreted phosphoprotein 1, leukocyte elastase inhibitor, nuclear factor-kappaB, cyclic adenosine monophosphate response element binding protein, DNA ligase 1, heat shock protein 90, and some EST genes. Northern hybridization and flow cytometry analysis also confirmed that PTEN overexpression results in the reduced expression of the integrin alpha(6) subunit. The results of this study indicate that PTEN overexpression may inhibit lung cancer invasion by downregulation of a panel of genes including integrin alpha(6). The cDNA microarray technique may be an effective tool to study the downstream function of a tumor suppressor gene.
Collapse
|
491
|
Huang HB, Chen YC, Tsai LH, Wang H, Lin FM, Horiuchi A, Greengard P, Nairn AC, Shiao MS, Lin TH. Backbone 1H, 15N, and 13C resonance assignments of inhibitor-2 -- a protein inhibitor of protein phosphatase-1. JOURNAL OF BIOMOLECULAR NMR 2000; 17:359-360. [PMID: 11014604 DOI: 10.1023/a:1008355428294] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
|
492
|
Chang SC, Fang CT, Hsueh PR, Chen YC, Luh KT. Klebsiella pneumoniae isolates causing liver abscess in Taiwan. Diagn Microbiol Infect Dis 2000; 37:279-84. [PMID: 10974581 DOI: 10.1016/s0732-8893(00)00157-7] [Citation(s) in RCA: 63] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Klebsiella pneumoniae has been the leading cause of pyogenic liver abscess in Taiwan during the period from 1985 to 1999, which is different from other countries. The present study investigated the in vitro antimicrobial susceptibilities of 51 K. pneumoniae isolates collected from blood cultures of patients with liver abscess in Taiwan during the period from 1993-1997, and typed by pulsed-field gel electrophoresis (PFGE). All 51 isolates were resistant to ampicillin, but susceptible to other antimicrobial agents. The minimum inhibitory concentrations (MICs) were less than 1 microg/ml for the third- and fourth-generation cephalosporins, monobactam, carbapenems, and ciprofloxacin. In comparison, 62 isolates of K. pneumoniae from community-acquired bacteremic patients without liver abscess had similar antimicrobial susceptibilities, while 142 isolates from patients with hospital-acquired bacteremia without liver abscess were much less susceptible to all of the tested antimicrobial agents. PFGE molecular epidemiologic analysis found 20 out of 51 isolates belonged to eight clusters of genetically related strains, with two or three isolates in each clusters. The other 31 isolates were genetically distinct strains. This study demonstrated that K. pneumoniae isolates which cause liver abscess in Taiwan remained susceptible to a wide range of antimicrobial agents and that they were not genetically related.
Collapse
|
493
|
Cao HH, Wang YC, Chen YC, Zhang Y, Ferretti L. [Studies of beef performance traits in Piemontese x Nanyang crossbred using microsatellites as genetic markers]. YI CHUAN XUE BAO = ACTA GENETICA SINICA 2000; 26:621-6. [PMID: 10876662] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/16/2023]
Abstract
Five microsatellites, IDVGA-2, IDVGA-27, IDVGA-46, IDVGA-55 and TGLA-44 were associated to beef performance traits of 100 heads of Nanyang cattle, Piemontese and their hybrid cattle using general linear model (GLM) with statistical analysis system (SAS). For microsatellite IDVGA-27, allele 136 had a positive relation with heart girth, height at hip cross and chest depth (body measurements) and loin width (muscularity evaluation); however, allele 142 showed a significant negative correlation with above performance traits. For IDVGA-46, the individuals with allele 205 had a good muscular development at loin width, on the contrary, the allele 211, which was not found in Piemontese cattle, had a negative correlation with shoulder development. Allele 203 (IDVGA-55) had a positive association with body measurement parameters including wither height, body length, height at hip cross and rump width.
Collapse
|
494
|
Liu HT, Hsu C, Chen CL, Chiang IP, Chen LT, Chen YC, Cheng AL. Chemotherapy alone versus surgery followed by chemotherapy for stage I/IIE large-cell lymphoma of the stomach. Am J Hematol 2000. [PMID: 10861812 DOI: 10.1002/1096-8652(200007)64:3<175::aid-ajh6>3.0.co;2-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
The optimal treatment of localized large-cell lymphoma of the stomach remains controversial. In particular, the role of surgical resection of the primary tumor needs to be clearly defined. We have reviewed all patients with a diagnosis of gastric lymphoma and treated in our institutions between 1988 and 1998. Patients fulfilling the following criteria were included in this study: (1) histologically proven large-cell lymphoma of the stomach; (2) adequate pathological materials and complete clinical information for analysis; (3) clinical stage I/II disease according to the Musshoff modification of Ann Arbor system; and (4) received primary chemotherapy alone with anthracycline- or anthracenedione-containing regimens (group A) or curative surgery followed by adjuvant chemotherapy (group B). There were 38 and 21 patients in group A and group B, respectively. All pertinent clinicopathologic features were similar between the two groups of patients, except that patients of group A had significantly more stage II-2 disease (P = 0.004). Of group A, among 36 patients who could be evaluated for response to chemotherapy, there were 29 complete and 1 partial responses, with an overall response rate of 83.3% (95% CI, 71.1-95.5%). The projected 5-year relapse-free survival (RFS) and overall survival (OS) were 86.0% (95% CI, 73.3-98.7%) and 72.6% (95% CI, 57.0-88.2%), respectively. On the other hand, the projected 5-year RFS and OS of group B were 77.9% (95% CI, 58.0-97.8%) and 77.8% (95% CI, 57.9-97. 7%), respectively, not significantly different from that of group A. Our data suggest that systemic chemotherapy alone may be a reasonable alternative treatment for stage I/II large-cell lymphoma of the stomach. Resection of the primary tumor before systemic chemotherapy does not appear to improve the cure rate of this group of patients.
Collapse
|
495
|
Liu HT, Hsu C, Chen CL, Chiang IP, Chen LT, Chen YC, Cheng AL. Chemotherapy alone versus surgery followed by chemotherapy for stage I/IIE large-cell lymphoma of the stomach. Am J Hematol 2000. [PMID: 10861812 DOI: 10.1002/1096-8652(200007)64:3%3c175::aid-ajh6%3e3.0.co;2-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
The optimal treatment of localized large-cell lymphoma of the stomach remains controversial. In particular, the role of surgical resection of the primary tumor needs to be clearly defined. We have reviewed all patients with a diagnosis of gastric lymphoma and treated in our institutions between 1988 and 1998. Patients fulfilling the following criteria were included in this study: (1) histologically proven large-cell lymphoma of the stomach; (2) adequate pathological materials and complete clinical information for analysis; (3) clinical stage I/II disease according to the Musshoff modification of Ann Arbor system; and (4) received primary chemotherapy alone with anthracycline- or anthracenedione-containing regimens (group A) or curative surgery followed by adjuvant chemotherapy (group B). There were 38 and 21 patients in group A and group B, respectively. All pertinent clinicopathologic features were similar between the two groups of patients, except that patients of group A had significantly more stage II-2 disease (P = 0.004). Of group A, among 36 patients who could be evaluated for response to chemotherapy, there were 29 complete and 1 partial responses, with an overall response rate of 83.3% (95% CI, 71.1-95.5%). The projected 5-year relapse-free survival (RFS) and overall survival (OS) were 86.0% (95% CI, 73.3-98.7%) and 72.6% (95% CI, 57.0-88.2%), respectively. On the other hand, the projected 5-year RFS and OS of group B were 77.9% (95% CI, 58.0-97.8%) and 77.8% (95% CI, 57.9-97. 7%), respectively, not significantly different from that of group A. Our data suggest that systemic chemotherapy alone may be a reasonable alternative treatment for stage I/II large-cell lymphoma of the stomach. Resection of the primary tumor before systemic chemotherapy does not appear to improve the cure rate of this group of patients.
Collapse
|
496
|
Huan SY, Yang CH, Chen YC. Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: an useful salvage therapy. Leuk Lymphoma 2000; 38:283-93. [PMID: 10830735 DOI: 10.3109/10428190009087019] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Arsenic trioxide (As2O3) was recently identified as a very potent agent against acute promyelocytic leukemia (APL). Intravenous infusion of 10 mg As2O3 daily for one to two months can induce significant complete remission (CR) of APL, and there is no cross drug-resistance between As2O3 and other antileukemic agents, including all-trans retinoic acid (ATRA). The CR rate of relapsed and/or refractory APL patients who received As2O3 treatment ranged from 52.3% to 93.3%. The median duration to CR ranged from 38 to 51 days, with accumulative As2O3 dosage of 340-430 mg. Although most adverse reactions of As2O3 treatment were tolerable, certain infrequent but severe toxicities related to As2O3 were observed, including renal failure, hepatic damage, cardiac arrhythmia and chronic neuromuscular degeneration, which should be monitored carefully. As2O3 can induce partial differentiation and subsequent apoptosis of APL cells through degradation of wild type PML and PML/RAR alpha chimeric proteins and possible anti-mitochondrial effects. Like the treatment of ATRA in APL, early relapses from As2O3 treatment within a few months were not infrequently seen, indicating that rapid emerging resistance to As2O3 can occur. Nevertheless, the PML/RAR alpha fusion protein was reported to disappear in some APL patients who received As2O3, and who might earn long-survival. However, the follow-up is still too short to draw the conclusion. Intriguingly, it has been shown that As2O3 can also induce apoptosis of other non-APL tumor cells with clinical achievable concentrations. However, the detailed molecular mechanisms are not yet fully understood. Further studies regarding to the pharmacological characters, clinical efficacies, toxicities, apoptogenic mechanisms, and spectrum of anti-tumor activity of As2O3 are warranted.
Collapse
MESH Headings
- Acute Kidney Injury/chemically induced
- Antineoplastic Agents/adverse effects
- Antineoplastic Agents/pharmacology
- Antineoplastic Agents/therapeutic use
- Apoptosis/drug effects
- Arrhythmias, Cardiac/chemically induced
- Arsenic Trioxide
- Arsenicals/adverse effects
- Arsenicals/pharmacology
- Arsenicals/therapeutic use
- Cell Differentiation/drug effects
- Chemical and Drug Induced Liver Injury/etiology
- Drug Evaluation
- Drug Screening Assays, Antitumor
- Gastrointestinal Neoplasms/drug therapy
- Gastrointestinal Neoplasms/pathology
- Humans
- Leukemia, Promyelocytic, Acute/drug therapy
- Leukemia, Promyelocytic, Acute/mortality
- Leukemia, Promyelocytic, Acute/pathology
- Life Tables
- Medicine, Chinese Traditional
- Mitochondria/drug effects
- Models, Biological
- Neoplasm Proteins/antagonists & inhibitors
- Neoplasm Proteins/metabolism
- Neoplastic Stem Cells/drug effects
- Neuromuscular Diseases/chemically induced
- Oncogene Proteins, Fusion/antagonists & inhibitors
- Oncogene Proteins, Fusion/metabolism
- Oxides/adverse effects
- Oxides/pharmacology
- Oxides/therapeutic use
- Remission Induction
- Salvage Therapy
- Survival Analysis
- Treatment Outcome
- Tumor Cells, Cultured/drug effects
- Urinary Bladder Neoplasms/drug therapy
- Urinary Bladder Neoplasms/pathology
Collapse
|
497
|
|
498
|
Liu HT, Hsu C, Chen CL, Chiang IP, Chen LT, Chen YC, Cheng AL. Chemotherapy alone versus surgery followed by chemotherapy for stage I/IIE large-cell lymphoma of the stomach. Am J Hematol 2000; 64:175-9. [PMID: 10861812 DOI: 10.1002/1096-8652(200007)64:3<175::aid-ajh6>3.0.co;2-7] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
The optimal treatment of localized large-cell lymphoma of the stomach remains controversial. In particular, the role of surgical resection of the primary tumor needs to be clearly defined. We have reviewed all patients with a diagnosis of gastric lymphoma and treated in our institutions between 1988 and 1998. Patients fulfilling the following criteria were included in this study: (1) histologically proven large-cell lymphoma of the stomach; (2) adequate pathological materials and complete clinical information for analysis; (3) clinical stage I/II disease according to the Musshoff modification of Ann Arbor system; and (4) received primary chemotherapy alone with anthracycline- or anthracenedione-containing regimens (group A) or curative surgery followed by adjuvant chemotherapy (group B). There were 38 and 21 patients in group A and group B, respectively. All pertinent clinicopathologic features were similar between the two groups of patients, except that patients of group A had significantly more stage II-2 disease (P = 0.004). Of group A, among 36 patients who could be evaluated for response to chemotherapy, there were 29 complete and 1 partial responses, with an overall response rate of 83.3% (95% CI, 71.1-95.5%). The projected 5-year relapse-free survival (RFS) and overall survival (OS) were 86.0% (95% CI, 73.3-98.7%) and 72.6% (95% CI, 57.0-88.2%), respectively. On the other hand, the projected 5-year RFS and OS of group B were 77.9% (95% CI, 58.0-97.8%) and 77.8% (95% CI, 57.9-97. 7%), respectively, not significantly different from that of group A. Our data suggest that systemic chemotherapy alone may be a reasonable alternative treatment for stage I/II large-cell lymphoma of the stomach. Resection of the primary tumor before systemic chemotherapy does not appear to improve the cure rate of this group of patients.
Collapse
|
499
|
Affolder T, Akimoto H, Akopian A, Albrow MG, Amaral P, Amendolia SR, Amidei D, Anikeev K, Antos J, Apollinari G, Arisawa T, Asakawa T, Ashmanskas W, Atac M, Azfar F, Azzi-Bacchetta P, Bacchetta N, Bailey MW, Bailey S, de Barbaro P, Barbaro-Galtieri A, Barnes VE, Barnett BA, Barone M, Bauer G, Bedeschi F, Belforte S, Bellettini G, Bellinger J, Benjamin D, Bensinger J, Beretvas A, Berge JP, Berryhill J, Bertolucci S, Bevensee B, Bhatti A, Bigongiari C, Binkley M, Bisello D, Blair RE, Blocker C, Bloom K, Blumenfeld B, Blusk BS, Bocci A, Bodek A, Bokhari W, Bolla G, Bonushkin Y, Bortoletto D, Boudreau J, Brandl A, van den Brink S, Bromberg C, Brozovic M, Bruner N, Buckley-Geer E, Budagov J, Budd HS, Burkett K, Busetto G, Byon-Wagner A, Byrum KL, Campbell M, Caner A, Carithers W, Carlson J, Carlsmith D, Cassada J, Castro A, Cauz D, Cerri A, Chan AW, Chang PS, Chang PT, Chapman J, Chen C, Chen YC, Cheng MT, Chertok M, Chiarelli G, Chirikov-Zorin I, Chlachidze G, Chlebana F, Christofek L, Chu ML, Cihangir S, Ciobanu CI, Clark AG, Cobal M, Cocca E, Connolly A, Conway J, Cooper J, Cordelli M, Costanzo D, Cranshaw J, Cronin-Hennessy D, Cropp R, Culbertson R, Dagenhart D, DeJongh F, Dell'Agnello S, Dell'Orso M, Demina R, Demortier L, Deninno M, Derwent PF, Devlin T, Dittmann JR, Donati S, Done J, Dorigo T, Eddy N, Einsweiler K, Elias JE, Engels E, Erdmann W, Errede D, Errede S, Fan Q, Feild RG, Ferretti C, Fiori I, Flaugher B, Foster GW, Franklin M, Freeman J, Friedman J, Fukui Y, Galeotti S, Gallinaro M, Gao T, Garcia-Sciveres M, Garfinkel AF, Gatti P, Gay C, Geer S, Gerdes DW, Giannetti P, Giromini P, Glagolev V, Gold M, Goldstein J, Gordon A, Goshaw AT, Gorta Y, Goulianos K, Grassmann H, Green C, Groer L, Grosso-Pilcher C, Guenther M, Guillian G, Guimaraes da Costa J, Guo RS, Haber C, Hafen E, Hahn SR, Hall C, Handa T, Handler R, Hao W, Happacher F, Hara K, Hardman AD, Harris RM, Hartmann F, Hatakeyama K, Hauser J, Heinrich J, Heiss A, Hinrichsen B, Hoffman KD, Holck C, Hollebeek R, Holloway L, Hughes R, Huston J, Huth J, Ikeda H, Incagli M, Incandela J, Introzzi G, Iwai J, Iwata Y, James E, Jensen H, Jones M, Joshi U, Kambara H, Kamon T, Kaneko T, Karr K, Kasha H, Kato Y, Keaffaber TA, Kelley K, Kelly M, Kennedy RD, Kephart R, Khazins D, Kikuchi T, Kirk M, Kim BJ, Kim HS, Kim MJ, Kim SH, Kim YK, Kirsch L, Klimenko S, Knoblauch D, Koehn P, Köngeter A, Kondo K, Konigsberg J, Kordas K, Korn A, Korytov A, Kovacs E, Kroll J, Kruse M, Kuhlmann SE, Kurino K, Kuwabara T, Laasanen AT, Lai N, Lami S, Lammel S, Lamoureux JI, Lancaster M, Latino G, LeCompte T, Lee AM, Leone S, Lewis JD, Lindgren M, Liss TM, Liu JB, Liu YC, Lockyer N, Loken J, Loreti M, Lucchesi D, Lukens P, Lusin S, Lyons L, Lys J, Madrak R, Maeshima K, Maksimovic P, Malferrari L, Mangano M, Mariotti M, Martignon G, Martin A, Matthews JA, Mazzanti P, McFarland KS, McIntyre P, McKigney E, Menguzzato M, Mezione A, Meschi E, Mesropian C, Miao C, Miao T, Miller R, Miller JS, Minato H, Miscetti S, Mishina M, Moggi N, Moore E, Moore R, Morita Y, Mukherjee A, Muller T, Munar A, Murat P, Murgia S, Musy M, Nachtman J, Nahn S, Nakada H, Nakaya T, Nakano I, Nelson C, Neuberger D, Newman-Holmes C, Ngan CY, Nicolaidi P, Niu H, Nodulman L, Nomerotski A, Oh SH, Ohmoto T, Ohsugi T, Oishi R, Okusawa T, Olsen J, Pagliarone C, Palmonari F, Paoletti R, Papadimitriou V, Pappas SP, Parri A, Partos D, Patrick J, Pauletta G, Paulini M, Paus C, Perazzo A, Pescara L, Phillips TJ, Piacentino G, Pitts KT, Plunkett R, Pompos A, Pondrom L, Pope G, Popovic M, Prokoshin F, Proudfoot J, Ptohos F, Punzi G, Ragan K, Rakitine A, Reher D, Reichold A, Riegler W, Ribon A, Rimondi F, Ristori L, Robertson WJ, Robinson A, Rodrigo T, Rolli S, Rosenson L, Roser R, Rossin R, Sakumoto WK, Saltzberg D, Sansoni A, Santi L, Sato H, Savard P, Schlabach P, Schmidt EE, Schmidt MP, Schmitt M, Scodellaro L, Scott A, Scribano A, Segler S, Seidel S, Seiya Y, Semenov A, Semeria F, Shah T, Shapiro MD, Shepard PF, Shibayama T, Shimojima M, Shochet M, Siegrist J, Signorelli G, Sill A, Sinervo P, Singh P, Slaughter AJ, Sliwa K, Smith C, Snider FD, Solodsky A, Spalding J, Speer T, Sphicas P, Spinella F, Spiropulu M, Spiegel L, Stanco L, Steele J, Stefanini A, Strologas J, Strumia F, Stuart D, Sumorok K, Suzuki T, Takashima R, Takikawa K, Tanaka M, Takano T, Tannenbaum B, Taylor W, Tecchio M, Teng PK, Terashi K, Tether S, Theriot D, Thurman-Keup R, Tipton P, Tkaczyk S, Tollefson K, Tollestrup A, Toyoda H, Trischuk W, de Troconiz JF, Truitt S, Tseng J, Turini N, Ukegawa F, Valls J, Vejcik S, Velev G, Vidal R, Vilar R, Vologouev I, Vucinic D, Wagner RG, Wagner RL, Wahl J, Wallace NB, Walsh AM, Wang C, Wang CH, Wang MJ, Watanabe T, Waters D, Watts T, Webb R, Wenzel H, Wester WC, Wicklund AB, Wicklund E, Williams HH, Wilson P, Winer BL, Winn D, Wolbers S, Wolinski D, Wolinski J, Worm S, Wu X, Wyss J, Yagil A, Yao W, Yeh GP, Yeh P, Yoh J, Yosef C, Yoshida T, Yu I, Yu S, Zanetti A, Zetti F, Zucchelli S. Search for scalar top and scalar bottom quarks in pp collisions at square root s=1.8 TeV. PHYSICAL REVIEW LETTERS 2000; 84:5704-5709. [PMID: 10991036 DOI: 10.1103/physrevlett.84.5704] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/25/1999] [Indexed: 05/23/2023]
Abstract
We have searched for direct pair production of scalar top and scalar bottom quarks in 88 pb-1 of pp collisions at sqrt[s]=1.8 TeV with the CDF detector. We looked for events with a pair of heavy flavor jets and missing energy, consistent with scalar top (bottom) quark decays to a charm (bottom) quark and a neutralino. The numbers of events that pass our selections show no significant deviation from standard model expectations. We compare our results to the next-to-leading order scalar quark production cross sections to exclude regions in scalar quark-neutralino mass parameter space.
Collapse
|
500
|
Chen YC, Eisner JD, Kattar MM, Rassoulian-Barrett SL, LaFe K, Yarfitz SL, Limaye AP, Cookson BT. Identification of medically important yeasts using PCR-based detection of DNA sequence polymorphisms in the internal transcribed spacer 2 region of the rRNA genes. J Clin Microbiol 2000; 38:2302-10. [PMID: 10834993 PMCID: PMC86787 DOI: 10.1128/jcm.38.6.2302-2310.2000] [Citation(s) in RCA: 150] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Identification of medically relevant yeasts can be time-consuming and inaccurate with current methods. We evaluated PCR-based detection of sequence polymorphisms in the internal transcribed spacer 2 (ITS2) region of the rRNA genes as a means of fungal identification. Clinical isolates (401), reference strains (6), and type strains (27), representing 34 species of yeasts were examined. The length of PCR-amplified ITS2 region DNA was determined with single-base precision in less than 30 min by using automated capillary electrophoresis. Unique, species-specific PCR products ranging from 237 to 429 bp were obtained from 92% of the clinical isolates. The remaining 8%, divided into groups with ITS2 regions which differed by </=2 bp in mean length, all contained species-specific DNA sequences easily distinguishable by restriction enzyme analysis. These data, and the specificity of length polymorphisms for identifying yeasts, were confirmed by DNA sequence analysis of the ITS2 region from 93 isolates. Phenotypic and ITS2-based identification was concordant for 427 of 434 yeast isolates examined using sequence identity of >/=99%. Seven clinical isolates contained ITS2 sequences that did not agree with their phenotypic identification, and ITS2-based phylogenetic analyses indicate the possibility of new or clinically unusual species in the Rhodotorula and Candida genera. This work establishes an initial database, validated with over 400 clinical isolates, of ITS2 length and sequence polymorphisms for 34 species of yeasts. We conclude that size and restriction analysis of PCR-amplified ITS2 region DNA is a rapid and reliable method to identify clinically significant yeasts, including potentially new or emerging pathogenic species.
Collapse
|